CONTROVERSIES AND NEW APPROACHES TO TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 12 (2) , 339-357
- https://doi.org/10.1016/s0889-8588(05)70514-1
Abstract
No abstract availableKeywords
This publication has 170 references indexed in Scilit:
- Tumor cell survival and resistance to therapyCurrent Opinion in Hematology, 1996
- A Monoclonal Antibody to cis-Urocanic Acid Prevents the Ultraviolet-Induced Changes in Langerhans Cells and Delayed Hypersensitivity Responses in Mice, Although Not Preventing Dendritic Cell Accumulation in Lymph Nodes Draining the Site of Irradiation and Contact Hypersensitivity ResponsesJournal of Investigative Dermatology, 1995
- Langerhans cell histiocytosisThe Journal of Pediatrics, 1995
- Treatment of adult Langerhans cell histiocytosis with etoposideJournal of the American Academy of Dermatology, 1992
- Topical nitrogen mustard: An effective treatment for cutaneous Langerhans cell histiocytosisPublished by Elsevier ,1991
- The Frequency and Natural History of Diabetes Insipidus in Children with Langerhans-Cell HistiocytosisNew England Journal of Medicine, 1989
- Allogeneic Bone Marrow Transplantation in a Patient with Chemotherapy-Resistant Progressive Histiocytosis XNew England Journal of Medicine, 1987
- Allogeneic Bone Marrow Transplantation in a Patient with Chemotherapy-Resistant Progressive Histiocytosis XNew England Journal of Medicine, 1987
- Histiocytosis-XNew England Journal of Medicine, 1981
- Histiocytosis X—comparison of three treatment regimensThe Journal of Pediatrics, 1975